Hypertrophy of the heart: calcineurin-NFAT pathway may be a new therapeutic target.
- Author:
Ying-Jun ZHANG
1
;
Lan-Feng DONG
;
Yong-Li WANG
Author Information
1. Department of Pharmacology, Hebei Medical University, Shijiazhuang 050017, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Calcineurin;
genetics;
physiology;
Cardiomegaly;
genetics;
physiopathology;
prevention & control;
Cyclosporine;
pharmacology;
therapeutic use;
Gene Expression;
Humans;
Immunosuppressive Agents;
pharmacology;
therapeutic use;
NFATC Transcription Factors;
genetics;
physiology;
Signal Transduction;
drug effects;
genetics;
physiology;
Tacrolimus;
pharmacology;
therapeutic use
- From:
Acta Pharmaceutica Sinica
2006;41(10):913-916
- CountryChina
- Language:Chinese
